[an error occurred while processing this directive] | [an error occurred while processing this directive]
A study of influencing factors and predictors for radiation encephalic necrosis after CyberKnife radiotherapy
Guo Yihang, Zhuang Hongqing, Yuan Zhiyong, Wang Ping
Cyberknife Center, Department of Radiotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer,Tianjin 300060,China
Abstract Objective To investigate the influencing factors and predictors for radiation encephalic necrosis after CyberKnife radiotherapy. Methods Ninety-four patients (104 targets) with primary or metastatic intracranial tumors who were treated with CyberKnife radiotherapy from 2006 to 2011 were retrospectively analyzed. All surgeries adopted skull tracking modes with a dose of 12-45 Gy in 1-8 fractions prescribed to 60%-87% isodose line. Radiation encephalic necrosis was determined by imaging or pathological examination. Logistic regression analysis was used to analyze the relationship between radiation encephalic necrosis and factors including diabetes, cardio-cerebrovascular diseases, target volume, isodose line, prescribed dose, number of fractions, combination with whole-brain irradiation (WBI), and biologically equivalent dose (BED). Predictability and critical threshold of all influencing factors forradiation encephalic necrosis were determined by the receiver operating characteristic (ROC) curve. ResultsTwelve targets (11.54%) had radiation encephalic necrosis. According to the result of logistic regression analysis, BED, combination with WBI, and number of fractions were influencing factors for radiation encephalic necrosis. In the ROC curves, the areas under curves for the above three factors were 0.892±0.034, 0.650±0.072, and 0.712±0.064, respectively, indicating that only BED can well predict radiation encephalic necrosis after CyberKnife radiotherapy with a dose threshold of>7410 cGy. Conclusions BED, combination with WBI, and number of fractions are influencing factors for radiation encephalic necrosis. BED is the best predictor of radiation encephalic necrosis with a dose threshold of>7410 cGy.
Guo Yihang,Zhuang Hongqing,Yuan Zhiyong et al. A study of influencing factors and predictors for radiation encephalic necrosis after CyberKnife radiotherapy[J]. Chinese Journal of Radiation Oncology, 2015, 24(3): 295-298.
Guo Yihang,Zhuang Hongqing,Yuan Zhiyong et al. A study of influencing factors and predictors for radiation encephalic necrosis after CyberKnife radiotherapy[J]. Chinese Journal of Radiation Oncology, 2015, 24(3): 295-298.
[1] Conti A, Pontoriero A, Arpa D, et al. Efficacy and toxicity of CyberKnife re-irradiation and"dose dense" temozolomide for recurrent gliomas[J]. Acta Neurochir (Wien),2012,154(2):203-209.DOI:10.1007/s00701-011-1184-1. [2] Jiang B, Veeravagu A, Lee M, et al. Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery[J]. J Clin Neurosci,2012,19(8):1101-1106.DOI:10.1016/j.jocn.2012.01.005. [3] Kim YZ, Kim DY, Yoo H, et al. Radiation-induced necrosis deteriorating neurological symptoms and mimicking progression of brain metastasis after stereotactic-guided radiotherapy[J]. Cancer Res Treat,2007,39(1):16-21. [4] Milker-Zabel S, Zabel A, Thilmann C, et al. Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma[J]. J Neurooncol,2002,60(3):227-233. [5] Olson AC, Wegner RE, Rwigema JC, et al. Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgery[J]. J Cancer Res Ther,2012,8(3):411-416.DOI:10.4103/0973-1482.103522. [6] Sio TT, Jang S, Lee SW, et al. Comparing Gamma Knife and CyberKnife in patients with brain metastases[J]. J Appl Clin Med Phys,2014,15(1):4095.DOI:10.1120/jacmp.v15i1.4095. [7] Kickingereder P, Dorn F, Blau T, et al. Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis:case report and review of the literature[J/OL].Radiat Oncol,2013,8:52[2014-07-10].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608155/. DOI:10.1186/1748-717X-8-52. [8] Shah R, Vattoth S, Jacob R, et al. Radiation necrosis in the brain:imaging features and differentiation from tumor recurrence[J].Radiographics,2012,32(5):1343-1359.DOI:10.1148/rg.325125002. [9] Stockham AL, Ahluwalia M, Reddy CA, et al. Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS[J].Neurooncol,2013,115(3):469-475.DOI:10.1007/s11060-013-1248-6. [10] Chernov MF,Hayashi M, Izawa M, et al. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases[J]. Brain Tumor Pathol,2006,23(1):19-27.DOI:10.1007/s10014-006-0194-9. [11] Kang TW,Kim ST, Byun HS, et al. Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis[J]. Eur J Radiol,2009,72(3):370-380.DOI:10.1016/j.ejrad. [12] Reddy K,Westerly D, Chen C. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas[J]. J Med Imaging Radiat Oncol,2013,57(3):349-355.DOI:10.1111/j.1754-9485. [13] Ozsunar Y, Mullins ME, Kwong K, et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging[J]. Acad Radiol,2010,17(3):282-290.DOI:10.1016/j.acra. [14] Pearlstein RD, Higuchi Y, Moldovan M, et al. Metalloporphyrin antioxidants ameliorate normal tissue radiation damage in rat brain[J]. Int J Radiat Biol,2010,86(2):145-163.DOI:10.3109/09553000903419965. [15] Siu A, Wind JJ, Iorgulescu JB, et al. Radiation necrosis following treatment of high grade glioma—a review of the literature and current understanding[J]. Acta Neurochir (Wien),2012,154(2):191-201.DOI:10.1007/s00701-011-1228-6. [16] Coderre JA, Morris GM, Micca PL, et al. Late effects of radiation on the central nervous system:role of vascular endothelial damage and glial stem cell survival[J]. Radiat Res,2006,166(3):495-503. [17] Nordal RA, Nagy A, Pintilie M, et al. Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury:a role for vascular endothelial growth factor[J]. Clin Cancer Res,2004,10(10):3342-3353. [18] Ye JH, Rong XM, Xiang YQ, et al. A study of radiation-induced cerebral vascular injury in nasopharyngeal carcinoma patients withradiation-induced temporal lobe necrosis[J/OL]. PLoS One,2012,7(8):e42890[2014-07-10].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418223/.DOI:10.1371/journal.pone.0042890. [19] Lee AW,Ng WT, Hung WM, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient-and treatment-related risk factors[J]. Int J Radiat Oncol Biol Phys,2009,73(4):1121-1128.DOI:10.1016/j.ijrobp. [20] Soussain C, Ricard D, Fike JR, et al. CNS complications of radiotherapy and chemotherapy[J].Lancet,2009,374(9701):1639-1651.DOI:10.1016/S0140-6736(09)61299-X. [21] Bhansali A, Banerjee AK, Chanda A, et al. Radiation-induced brain disorders in patients with pituitary tumours[J]. Australas Radiol,2004,48(3):339-346. [22] Miyata T,Toho T, Nonoguchi N, et al. The roles of platelet-derived growth factors and their receptors in brain radiation necrosis[J/OL]. Radiat Oncol,2014,9:51[2014-07-10].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927833/DOI:10.1186/1748-717X-9-51.
2015, Vol. 24 
